MedPath
FDA Approval

Mirena

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
August 12, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levonorgestrel(52 mg in 1 1)

Manufacturing Establishments3

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bayer Pharma Oy

Bayer HealthCare Pharmaceuticals Inc.

369758383

Sterigenics Belgium Petit-Rechain S.A.

Bayer HealthCare Pharmaceuticals Inc.

370026481

Bayer AG

Bayer HealthCare Pharmaceuticals Inc.

342872971

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mirena

Product Details

NDC Product Code
50419-423
Application Number
NDA021225
Marketing Category
NDA (C73594)
Route of Administration
INTRAUTERINE
Effective Date
December 21, 2016
Code: 5W7SIA7YZWClass: ACTIBQuantity: 52 mg in 1 1
DIMETHICONEInactive
Code: 92RU3N3Y1OClass: IACT
BARIUM SULFATEInactive
Code: 25BB7EKE2EClass: IACT
© Copyright 2025. All Rights Reserved by MedPath